CLL-1 was the only potential CAR T cell target in JMML that was overexpressed in both scRNAseq and mass spectrometry versus healthy controls and had a low expression in healthy tissue. This evidence concerns the gene CLEC12A and juvenile myelomonocytic leukemia.